What Causes Lymph Nodes to Light Up on a PET Scan?

Lymph nodes light up on a PET scan whenever the cells inside them are consuming glucose at a faster-than-normal rate. The radioactive tracer used in most PET scans is a modified sugar molecule, and any tissue burning through glucose quickly will absorb more of it, creating a bright spot on the image. Cancer is the most feared reason, but infections, inflammatory diseases, recent vaccinations, and even inhaled dust particles can all drive lymph nodes to glow. The clinical challenge is figuring out which cause is responsible in any given patient.

How the Tracer Works

The standard PET scan tracer is a glucose molecule tagged with a small amount of radioactive fluorine. Once injected into the bloodstream, it travels throughout the body and gets taken up by cells that are hungry for energy. Cancer cells tend to be ravenous, pulling in glucose at rates far higher than most normal tissues. But they are not the only cells that do this. Immune cells ramping up to fight an infection or an inflammatory trigger also consume large amounts of glucose. The scanner detects the radioactive signal wherever the tracer accumulates, and those areas appear as bright “hot spots” on the image.

This is why a PET scan is powerful but not perfectly specific. It tells your doctor where metabolic activity is elevated. It does not, on its own, tell them why. A lymph node packed with metastatic tumor cells and a lymph node full of activated immune cells fighting tuberculosis can look strikingly similar. That ambiguity is central to how PET results are interpreted, and it drives much of the follow-up testing patients undergo.

Cancer and Metastatic Lymph Nodes

The most common clinical reason for ordering a PET scan is to evaluate whether cancer has spread. When tumor cells migrate from their original site to nearby or distant lymph nodes, those nodes tend to show intense tracer uptake. In lung cancer staging, for instance, metastatic lymph nodes had significantly higher uptake values than cancer-free nodes.¹ However, the overlap between cancerous and non-cancerous nodes is substantial. In one study of lung cancer patients, using a specific uptake threshold to identify metastatic nodes yielded a sensitivity of only about 48% and a specificity of roughly 80%, meaning the scan missed about half of truly involved nodes while still flagging some benign ones as suspicious.²

That imperfect accuracy matters enormously for treatment planning. A false-positive lymph node could push a surgeon to recommend a more aggressive operation or rule out surgery entirely, while a false-negative could leave cancer behind. Older patients and those with bilateral uptake in hilar lymph nodes were more likely to have false-positive results in lung cancer staging.² This is one reason PET findings alone rarely dictate the final treatment decision without tissue sampling.

Infections That Mimic Malignancy

Infections are among the most common non-cancerous causes of lymph nodes lighting up on PET. Tuberculosis is a prime example: the immune response to TB involves activated macrophages and other white blood cells clustered in structures called granulomas, and these cells are metabolically hyperactive. Active TB lesions in lymph nodes can show tracer uptake intense enough to mimic lymphoma or metastatic disease.³ This problem is well-recognized in regions where TB is common, but it also crops up in areas where the disease is less expected.

TB is far from the only infectious culprit. Fungal infections such as histoplasmosis, aspergillosis, and coccidioidomycosis, as well as bacterial pneumonia and other granulomatous processes, can all produce false-positive results on PET scans performed for cancer evaluation.⁴ In some parts of the United States, for example, histoplasmosis is endemic in river valleys and can cause mediastinal lymph nodes (the nodes in the center of the chest) to glow brightly on a PET scan years after the initial infection, thanks to residual granulomatous inflammation. A radiologist unfamiliar with the patient’s geographic history might interpret those nodes as concerning for cancer.

Sarcoidosis and Other Inflammatory Conditions

Sarcoidosis deserves its own mention because it is a frequent source of confusion on PET imaging. This inflammatory disease produces clusters of immune cells (noncaseating granulomas) that can appear in virtually any organ but have a strong tendency to involve the lungs and the lymph nodes inside the chest. PET scanning is sensitive enough to detect active sarcoidosis in any organ.⁵ The trouble is that the pattern of bright, symmetrically enlarged mediastinal and hilar lymph nodes in sarcoidosis can look nearly identical to lymphoma on a PET scan.

Other autoimmune and inflammatory conditions can behave similarly. Rheumatoid arthritis, lupus, and various vasculitis syndromes can all trigger reactive lymph node enlargement with enough metabolic activity to register on PET. A review of over a thousand PET scans found that more than a quarter contained incidental areas of benign tracer uptake, with most attributed to infectious or non-infectious inflammation.⁶ In practical terms, if you already have a known inflammatory condition, your doctor needs to weigh that heavily when interpreting any hot lymph nodes on your scan.

Vaccination and Other Everyday Triggers

COVID-19 vaccination brought widespread attention to a phenomenon radiologists had seen with other vaccines but rarely at such scale. After receiving an mRNA vaccine in the deltoid muscle of one arm, people frequently developed enlarged, metabolically active lymph nodes in the armpit, above the collarbone, and in the neck on the same side as the injection.⁷ Multiple studies confirmed that this FDG-avid lymph node enlargement was a specific and predictable feature following COVID-19 vaccination.⁸

For cancer patients undergoing PET scans for staging or surveillance, this created a real dilemma. A bright axillary node on the same side as a recent vaccine could represent either a normal immune response or disease progression, and distinguishing the two on the scan alone was often impossible. Many cancer centers responded by advising patients to schedule their vaccinations in the arm opposite to any known tumor, or to wait a few weeks between vaccination and a PET scan. The uptake is typically transient, fading over weeks, but it can persist long enough to cause anxiety and unnecessary biopsies.

Flu shots and other intramuscular vaccinations can cause the same phenomenon, though it drew less attention before the pandemic. The takeaway is practical: always tell your imaging team about recent vaccinations, including the date and which arm received the shot.

Inhaled Particles and Environmental Exposures

Here is a cause that surprises many patients: inhaling carbon-based particles over years can cause lymph nodes to light up. This condition, called anthracotic lymphadenitis, involves the accumulation of dark carbon deposits in lymph nodes that drain the lungs. The nodes mount a low-grade inflammatory response to the foreign material, which is enough to create PET-visible uptake. In one study of patients undergoing cancer evaluation, a large share of PET-positive lymph nodes turned out to be anthracotic rather than malignant. Exposure histories included outdoor work in construction and landscaping, as well as indoor cooking with biomass fuels in poorly ventilated homes.⁹

Silicosis, caused by inhaling silica dust in mining or stonecutting, can produce a similar picture. When researchers broke down the actual causes of 100 PET-positive lymph node stations in lung cancer patients, only 14 were metastatic. Forty were anthracotic, 39 were simply reactive (meaning the immune system was mildly activated for no alarming reason), four were granulomatous, and three were due to silicosis.¹ In other words, the majority of “positive” nodes were benign. That statistic alone underscores why PET-positive does not automatically mean cancer.

Brown Fat Near Lymph Nodes

Brown fat is a type of body tissue that generates heat by burning calories, and it is metabolically active enough to light up intensely on PET scans. It commonly sits in the neck and supraclavicular areas, right where lymph nodes also cluster. About 4% of patients in one series showed supraclavicular foci of increased tracer uptake that turned out to be brown fat rather than pathological tissue, with the finding more common in women.¹⁰

When brown fat surrounds lymph nodes, the glow from the fat can be misread as coming from the nodes themselves. Radiologists handle this by carefully reviewing the CT portion of the PET/CT scan. If the lymph node looks completely normal in shape, size, and internal structure on CT, the uptake can be confidently attributed to surrounding brown fat.¹¹ Cold weather, low body weight, and younger age all increase brown fat activity, which is why this pitfall comes up more in winter months and in lean patients.

What the Numbers on a PET Report Mean

You will often see a number called SUVmax on your PET scan report. This is a standardized measure of how much tracer a particular spot has absorbed relative to the rest of the body. Higher values generally indicate more metabolic activity. In mediastinal lymph node evaluation, metastatic nodes had an average SUVmax around 7, while tumor-free nodes averaged about 2.4 and inflamed-but-benign nodes averaged about 2.7.¹²

The problem is the massive overlap. Some cancerous nodes barely register, and some inflamed nodes score very high. Researchers have searched for a single cutoff number that reliably separates malignant from benign. One large retrospective study found that for mediastinal lymph nodes, a threshold of about 3.6 yielded a sensitivity of 87% and specificity of 89%, while for cervical lymph nodes a lower threshold of about 2.2 achieved a sensitivity of 98% and specificity of 83%.¹³ The best threshold depends on the anatomic location, the type of cancer being evaluated, and the clinical context. There is no universal magic number.

So if your report says “SUVmax 5.2,” that does not automatically mean cancer. And an SUVmax of 2.0 does not guarantee everything is fine. Your doctor interprets the number alongside the node’s size, shape, location, and your clinical history.

When Cancer Does Not Light Up

Not all cancers are metabolically greedy enough to show up on PET. Certain tumor types have inherently low glucose consumption and can hide in lymph nodes without creating a bright signal. These include some low-grade lymphomas, carcinoid tumors, bronchioloalveolar carcinomas (now called adenocarcinoma in situ), and very small metastases.¹⁴ A false-negative PET scan can be more dangerous than a false-positive one, because it may give the impression that cancer has not spread when it actually has.

Certain patient-level factors also increase the risk of a false-negative result. In lung cancer staging, having concurrent lung disease or diabetes, and having a primary tumor with particular histologic characteristics, were all significantly associated with false-negative lymph node results.¹⁵ Diabetes is especially relevant because high blood sugar competes with the tracer for entry into cells. If your blood glucose is elevated at the time of the scan, the tracer may not be absorbed efficiently by tissues that would otherwise light up, potentially masking disease.¹⁶

How Doctors Sort Out Ambiguous Results

Given all the possible causes of a bright lymph node, clinicians use several strategies to narrow the diagnosis. The first line of defense is the CT component of a PET/CT scan. While PET shows metabolic activity, CT shows anatomy. A lymph node that is enlarged, round, and has lost its normal internal fat stripe is more suspicious for cancer than one that is normal-sized and oval-shaped, regardless of how brightly it glows.

One technique involves scanning the patient twice: once at the standard time after tracer injection and again an hour or two later. Malignant lymph nodes tend to keep accumulating tracer over time, so their uptake values increase on the delayed scan. Benign or inflammatory nodes are more likely to plateau or even decrease. In studies of lymphoma versus benign disease, applying a delayed-scan cutoff improved diagnostic specificity.¹⁷ Similarly, delayed imaging in bladder cancer patients showed better detection of metastatic nodes, and the pattern of tracer distribution within the node differed: metastatic nodes tended to show uptake throughout, while reactive nodes showed speckled patterns.¹⁸

When imaging alone cannot settle the question, tissue sampling becomes necessary. A biopsy can be performed with a needle guided by ultrasound or CT, or through a procedure called endobronchial ultrasound-guided needle aspiration for nodes in the chest. One study found that over half of PET-positive lesions that looked benign on CT, and about a third of PET-positive lymph nodes smaller than a centimeter, turned out to be malignant at biopsy.¹⁹ That finding reinforces the point that a reassuring appearance on CT does not always override a worrisome PET signal. The decision to biopsy involves weighing the probability of cancer against the risks and invasiveness of the procedure.

Emerging Tools for Better Accuracy

Researchers are exploring several approaches to reduce the ambiguity of PET-positive lymph nodes. One avenue is radiomics, in which software extracts hundreds of mathematical features from PET and CT images that the human eye cannot perceive. In breast cancer patients whose lymph nodes appeared normal on clinical exam, a machine learning model built on these radiomic features achieved a mean accuracy above 80% in predicting whether the nodes actually harbored metastatic disease.²⁰ These tools are still experimental and not yet standard in clinical practice, but they represent a promising direction.

Another approach involves using different tracers altogether. The standard glucose-based tracer lights up anything metabolically active, which is why so many benign conditions cause false alarms. Newer tracers are designed to bind to molecules found specifically on certain cancer cells. In prostate cancer, for example, a tracer targeting a protein on the surface of prostate cancer cells has shown strong performance in detecting lymph node metastases that glucose-based PET might miss or that infection could mimic. As these specialized tracers become more widely available, PET scanning for specific cancers is expected to become more precise, though the glucose tracer will likely remain the workhorse for general oncologic imaging for the foreseeable future.

What to Do Before and After Your Scan

A few practical details can meaningfully affect the quality of your PET scan. Because the tracer competes with natural glucose for entry into cells, high blood sugar at the time of injection blunts uptake and can produce falsely dim results. Most imaging centers will ask you to fast for several hours before the scan and may check your blood glucose. If you have diabetes, managing your blood sugar in the hours before the appointment is particularly important.¹⁶

Strenuous exercise the day before the scan can increase glucose uptake in muscles, potentially obscuring nearby lymph nodes or creating confusing hot spots. Cold temperatures activate brown fat, which as discussed earlier can cloud the picture in the neck and upper chest. Many centers keep the room warm and offer blankets for this reason. Staying relaxed and still during the uptake period (the hour or so between tracer injection and scanning) also reduces muscle uptake that could complicate interpretation.

After the scan, if lymph nodes have lit up, the most important thing is to share your full medical history with the team reading the images. Recent infections, vaccinations, travel to areas where certain fungal diseases are common, occupational dust exposure, known inflammatory conditions: all of this context helps the radiologist distinguish a worrisome finding from a benign one. A PET scan is not a standalone verdict. It is one piece of a diagnostic puzzle, and the more context your medical team has, the more accurately they can assemble the picture.